Remove Cardiovascular Interventions Remove Innovation Remove Tricuspid
article thumbnail

Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports

DAIC

It serves as a publication vehicle for early career cardiologists and members of the cardiovascular care team, providing a forum for mentorship on the review and publication process. Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field.

TAVR 105
article thumbnail

Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports

DAIC

It serves as a publication vehicle for early career cardiologists and members of the cardiovascular care team, providing a forum for mentorship on the review and publication process. Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field.

TAVR 52
article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes. million individuals and is growing in the United States.